Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo
Yuanyuan Zhao(East China University of Science and Technology), Li Zhang(Sun Yat-sen University)
Cited by 48
Related Papers
A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial
|Nature Medicine|2025|76
Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma
|Drug Design Development and Therapy|2018|14